Neuroscience
Parkinson's Disease
100%
Metrizamide
46%
Tremor
40%
Placebo
35%
Competitive Inhibition
28%
Selegiline
28%
Adenosine Triphosphatase (Potassium Sodium)
28%
Hexokinase
28%
Thyroxine
24%
Myelography
21%
Ropinirole
18%
Rasagiline
18%
2-Deoxy-D-Glucose
17%
Glucosamine
16%
Familial Parkinson's Disease
14%
Alzheimer's Disease
13%
L-DOPA
12%
Parkin
12%
Neurodegenerative Disorder
12%
In Vitro
11%
Dopaminergic
11%
Anti-Inflammatory
10%
Hypothyroidism
9%
Enflurane
9%
Diffusion MRI
9%
Auditory Brainstem Response
9%
Hindbrain
9%
Cerebrum
9%
Epinephrine
9%
Electroencephalography
9%
Electrical Brain Stimulation
9%
Aicardi Syndrome
9%
Aseptic Meningitis
9%
Thyroid Hormone
9%
Ataxia
9%
Leucine Rich Repeat Kinase 2
9%
Gene Interaction
9%
Brain Ischemia
9%
Ischemia
9%
Familial Creutzfeldt Jakob Disease
9%
Codon
9%
Supranuclear Palsy
9%
Creutzfeldt Jakob Disease
9%
Enzyme Activity
9%
Epidemiology of Parkinson's Disease
9%
Auditory System
9%
Treatment of Parkinson's Disease
9%
Melatonin
9%
Chronotropic
9%
Deep Brain Stimulation
9%
Keyphrases
Myelography
19%
Motor Fluctuations
19%
Parkinson's Disease
18%
Selegiline
18%
Orthostatic Tremor
18%
Dyskinesia
13%
Levodopa
13%
Movement Disorders
10%
Periodic Acid
9%
Pro-resolving Mediators
9%
Hexokinase
9%
Parkinson Patients
9%
Enflurane
9%
Glucosamine
9%
Postoperative Seizure
9%
Pakistan
9%
Orally Disintegrating Tablet
9%
APOE ε4 Allele
9%
Free Phenytoin
9%
Diurnal Variation
9%
Concentration Correlation
9%
Parkin mutation
9%
Neuroinflammation
9%
Creutzfeldt-Jakob Disease
9%
Supranuclear Palsy
9%
Late-onset Parkinson's Disease
9%
PbCl2
9%
Cation Pumps
9%
Deep Brain Stimulation
9%
MAO-B Inhibitors
9%
G2019S
9%
R1441C
9%
Aicardi-Goutières Syndrome
9%
Neurological Oncology
9%
Nurr1
9%
Focale
9%
Genome-wide Association Data
9%
Carpal Tunnel Syndrome
9%
Ganglion Cyst
9%
Gait Disorders
9%
Plantar
9%
Immediate Release
9%
Genome-wide Linkage Analysis
9%
Aseptic Meningitis
9%
Memory T Cell Subsets
9%
Gene-gene Interaction
9%
Screening Tool
9%
Neurodegenerative Diseases
9%
Melanoma Risk
9%
Spinocerebellar
9%
Medicine and Dentistry
Standing
28%
Parkinson's Disease
22%
Disease
12%
Rasagiline
9%
Clinical Significance
9%
Mediator
9%
Enflurane
9%
Neurodegenerative Disorder
9%
Familial Creutzfeldt Jakob Disease
9%
Supranuclear Palsy
9%
Creutzfeldt-Jakob Disease
9%
Monoamine Oxidase B Inhibitor
9%
Amine Oxidase (Flavin Containing)
9%
Electrical Brain Stimulation
9%
Atmospheric Aerosol
9%
Glucose Utilization
9%
Aicardi Syndrome
9%
Carpal Tunnel Syndrome
9%
Ganglion Cyst
9%
Treatment Effect
9%
COVID-19
9%
Gait Disorder
9%
Prospective Study
9%
Neuroinflammation
9%
Deep Brain Stimulation
9%
Selegiline
7%
Tumor Metabolism
6%
Visual Evoked Potential
6%
Symptom
5%
Alzheimer's Disease
5%